Production of pharmaceutical products for healthcare sectors including cardiology and critical care.
Annual revenue $119,312 Latest available
Total funding - Funding intelligence
Employees 8 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Latika Biotech

Latika Biotech is a company. The company has 8 employees as of April 07, 2024. Latika Biotech offers products and services including Onco Care Products and Critical Care Products.

  • Employees 8 as on 07 Apr, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Latika Biotech Pvt. Ltd
  • Jurisdiction Kolkata, West Bengal, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $119.31 K (USD)
    5.22
    as on Mar 31, 2023
  • Net Profit
    -$65.65 K (USD)
    -13.77
    as on Mar 31, 2023
  • EBITDA
    -$63.2 K (USD)
    -13.25
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    8

    as on Apr 07, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Latika Biotech

Latika Biotech offers a comprehensive portfolio of products and services, including Onco Care Products and Critical Care Products.

Product name locked
Category locked
Primary

Products like Amphotericin B and Oxaliplatin are manufactured for oncology care to address critical health needs.

Product name locked
Category locked
Locked

Products such as Meropenem and Cefriaxone are provided for critical care to support patient treatment in various medical scenarios.

Funding Insights of Latika Biotech

Premium access

Detailed funding history for Latika Biotech

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Latika Biotech

Investments
Premium access

Investment portfolio details for Latika Biotech

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Latika Biotech

Premium access

Detailed financials for Latika Biotech

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Latika Biotech Comparisons

Latika Biotech Primary company
Description
Production of pharmaceutical products for healthcare sectors...
Location
-
Founded Year
-
Annual Revenue
$119.31 K (USD)
Net Profit
-$65.65 K (USD)
EBITDA
-$63.2 K (USD)
Employees
8
As of 2024
Premium access

Peer comparison for Latika Biotech

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Latika Biotech

Premium access

Detailed competitors of Latika Biotech

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Latika Biotech

Premium access

Complete news archive for Latika Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Latika Biotech

As of Apr 07, 2024, the latest employee count at Latika Biotech is 8.

Annual revenue of Latika Biotech is $119.31K as on Mar 31, 2023.

Latika Biotech Pvt. Ltd. is known for manufacturing quality pharmaceutical products that aim to enhance global health outcomes. A commitment to reliability and innovation is demonstrated through ethical business practices and a diverse product line covering areas like gynecology, pediatrics, and critical care. Divisions such as Onco Care and Critical Care are utilized to develop drugs including Amphotericin B and Meropenem, which assist in treating various medical conditions. The company operates from Kolkata, India, with an international presence, and its efforts are directed towards supporting well-being worldwide.

Latika Biotech offers Onco Care Products and Critical Care Products.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available